A Paradox and Alan Rein: Distinguished Retrovirologist Retires from the HIV DRP

February is American Heart Month, and Feb. 7 was designated “National Wear Red Day” by the American Heart Association. The American Heart Association has sponsored the “Go Red for Women” campaign for 10 years. The message: heart disease is the number one killer of women. Did you know that more women die of heart disease than men?  In fact, it is more deadly than all forms of cancer combined. Over the years, the red dress has become the symbol of the fight against heart disease in women.

Nearly 700 researchers, scientists, and laboratory technicians convened in the Ronald Reagan Building and International Trade Center in Washington, DC, for the 2014 NCI Intramural Scientific Investigators Retreat on Jan. 14. The event featured presentations and posters exploring topics in cancer research from KRAS signaling to animal care. One of the highlights of the event was a presentation made by Valerie Beral, Ph.D., from University of Oxford, discussing “Rosalind Franklin and Cancer in Women.”

Whether in a research laboratory or an operations environment, past performance is frequently reviewed to plan for future improvements. Such was the case last year when management recognized the need to change the policy on the minimum set of personal protective equipment to be worn in the laboratories to reduce both the number and consequence of injuries at the Frederick National Laboratory for Cancer Research.

The HIV Drug Resistance Program (HIV DRP), Center for Cancer Research (CCR), will hold a conference on “Host Factors and Cofactors in HIV Infection” at the National Cancer Institute (NCI) campus in Frederick, Md., on Feb. 25, from 1:00 to 5:35 p.m.

Humans play host to trillions of microorganisms that help our bodies perform basic functions, like digestion, growth, and fighting disease. In fact, bacterial cells outnumber the human cells in our bodies by 10 to 1. The tens of trillions of microorganisms thriving in our intestines are known as gut microbiota, and those that are not harmful to us are referred to as commensal microbiota. In a recent paper in Science, NCI scientists described their discovery that, in mice, the presence of commensal microbiota is needed for successful response to cancer therapy.